Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

THERESE J SARGENT

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health

NPI
1851393433
CMS profile
129023
Location
PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$67,077.76

163 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

THERESE J SARGENT

NPI 1851393433 · CMS profile ID 129023

Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Adult Health

PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851393433?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
THERESE J SARGENT, NPI 1851393433, CMS profile ID 129023. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851393433?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). THERESE J SARGENT, NPI 1851393433, CMS profile ID 129023. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851393433?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
THERESE J SARGENT, NPI 1851393433, CMS profile ID 129023, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1851393433?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

163 matching records · $67,077.76 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 163 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 163.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
United Therapeutics Corporation $99.7910/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957945253 CMS
Bayer HealthCare Pharmaceuticals Inc. $186.3710/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965548693 CMS
Bayer HealthCare Pharmaceuticals Inc. $165.3710/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965548707 CMS
Bayer HealthCare Pharmaceuticals Inc. $186.5110/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965548695 CMS
Actelion Pharmaceuticals US, Inc. $10.3310/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369087 CMS
Actelion Pharmaceuticals US, Inc. $10.2610/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369009 CMS
Bayer HealthCare Pharmaceuticals Inc. $806.2010/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965548723 CMS
Actelion Pharmaceuticals US, Inc. $1,820.0009/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368983 CMS
Bayer HealthCare Pharmaceuticals Inc. $11.2409/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965543315 CMS
Actelion Pharmaceuticals US, Inc. $1,011.3709/15/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368981 CMS
Impulse Dynamics (USA) Inc. $138.9009/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947560293 CMS
Bayer HealthCare Pharmaceuticals Inc. $438.0009/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929856499 CMS
United Therapeutics Corporation $23.3509/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957961773 CMS
Actelion Pharmaceuticals US, Inc. $108.5108/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369027 CMS
Actelion Pharmaceuticals US, Inc. $21.4008/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369083 CMS
Actelion Pharmaceuticals US, Inc. $1,820.0008/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368977 CMS
Actelion Pharmaceuticals US, Inc. $329.7708/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368979 CMS
Actelion Pharmaceuticals US, Inc. $3.5108/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369035 CMS
Actelion Pharmaceuticals US, Inc. $149.4208/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368971 CMS
Actelion Pharmaceuticals US, Inc. $849.7508/18/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368973 CMS
Actelion Pharmaceuticals US, Inc. $252.3408/18/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368975 CMS
Actelion Pharmaceuticals US, Inc. $4.0808/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369037 CMS
Actelion Pharmaceuticals US, Inc. $1,560.0008/17/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368969 CMS
Actelion Pharmaceuticals US, Inc. $107.4908/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369077 CMS
Actelion Pharmaceuticals US, Inc. $12.4208/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369033 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,190.0008/04/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965548721 CMS
Actelion Pharmaceuticals US, Inc. $125.1807/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369085 CMS
Actelion Pharmaceuticals US, Inc. $61.0407/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369039 CMS
United Therapeutics Corporation $99.6707/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957945273 CMS
United Therapeutics Corporation $970.0007/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957945275 CMS
United Therapeutics Corporation $970.0007/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957945277 CMS
Actelion Pharmaceuticals US, Inc. $1,820.0007/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368961 CMS
Actelion Pharmaceuticals US, Inc. $18.8907/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885369023 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29.7307/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876399005 CMS
United Therapeutics Corporation $68.1006/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957961769 CMS
Merck Sharp & Dohme LLC $9.9806/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944449837 CMS
Bayer HealthCare Pharmaceuticals Inc. $136.6506/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929853405 CMS
Bayer HealthCare Pharmaceuticals Inc. $181.6506/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965548709 CMS
Actelion Pharmaceuticals US, Inc. $104.5106/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368959 CMS
Actelion Pharmaceuticals US, Inc. $551.2206/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368963 CMS
Actelion Pharmaceuticals US, Inc. $152.2606/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368965 CMS
Bayer HealthCare Pharmaceuticals Inc. $121.2206/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965548701 CMS
Bayer HealthCare Pharmaceuticals Inc. $472.9606/18/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929855109 CMS
Actelion Pharmaceuticals US, Inc. $390.0006/15/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368967 CMS
Actelion Pharmaceuticals US, Inc. $1,820.0006/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368929 CMS
Actelion Pharmaceuticals US, Inc. $1,820.0006/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368931 CMS
Actelion Pharmaceuticals US, Inc. $1,560.0006/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885368943 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,190.0006/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929855517 CMS
Merck Sharp & Dohme LLC $81.0506/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944447085 CMS
Bayer HealthCare Pharmaceuticals Inc. $1,971.0006/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929853117 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $23,158.22 60
PY2022 $67,077.76 163
PY2023 $106,448.62 226
PY2024 $51,632.17 130
PY2025 $58,643.33 100

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $113,403.44 28
PY2023 Principal investigator $21,208.40 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 United Therapeutics Corporation $2,145.00 12/31/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620980
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,481.20 12/05/2024 Non-covered Recipient Entity
Honorhealth Medical Group Admin Office
BAY 632521, RiOciguAt UseRs Registry The ROAR registry No dispute reported 06/30/2026 1085978534
Principal investigator 1 United Therapeutics Corporation $4,650.80 10/30/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620984
Principal investigator 1 United Therapeutics Corporation $2,145.00 10/09/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620976
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $765.00 09/26/2024 Non-covered Recipient Entity
Honorhealth Medical Group Admin Office
BAY 632521, RiOciguAt UseRs Registry The ROAR registry No dispute reported 06/30/2026 1085978528
Principal investigator 1 United Therapeutics Corporation $229.60 09/25/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620970
Principal investigator 1 United Therapeutics Corporation $1,194.44 09/25/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620972
Principal investigator 1 United Therapeutics Corporation $3,987.20 09/25/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620982
Principal investigator 1 United Therapeutics Corporation $2,145.00 08/28/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620978
Principal investigator 1 United Therapeutics Corporation $6,148.80 08/08/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620988
Principal investigator 1 United Therapeutics Corporation $105.00 07/31/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620968
Principal investigator 1 United Therapeutics Corporation $1,365.00 07/31/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620974
Principal investigator 1 United Therapeutics Corporation $0.80 07/10/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620966
Principal investigator 1 United Therapeutics Corporation $6,148.80 07/10/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620986
Principal investigator 1 United Therapeutics Corporation $2,210.00 06/26/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149621000
Principal investigator 1 United Therapeutics Corporation $1,295.00 06/12/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620998
Principal investigator 1 United Therapeutics Corporation $18,072.20 06/12/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149621010
Principal investigator 1 United Therapeutics Corporation $30,689.40 05/22/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149621012
Principal investigator 1 United Therapeutics Corporation $1,264.20 04/24/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620996
Principal investigator 1 United Therapeutics Corporation $3,699.60 04/24/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149621004
Principal investigator 1 United Therapeutics Corporation $3,810.00 04/24/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149621006
Principal investigator 1 United Therapeutics Corporation $1,239.20 04/10/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620992
Principal investigator 1 United Therapeutics Corporation $498.40 03/13/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620990
Principal investigator 1 United Therapeutics Corporation $3,500.00 03/13/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149621002
Principal investigator 1 United Therapeutics Corporation $7,268.00 03/13/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149621008
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,511.00 02/29/2024 Non-covered Recipient Entity
Honorhealth Medical Group Admin Office
BAY 632521, RiOciguAt UseRs Registry The ROAR registry No dispute reported 06/30/2026 1085978532
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,570.60 02/15/2024 Non-covered Recipient Entity
Honorhealth Medical Group Admin Office
BAY 632521, RiOciguAt UseRs Registry The ROAR registry No dispute reported 06/30/2026 1085978530
Principal investigator 1 United Therapeutics Corporation $1,264.20 02/14/2024 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1149620994